To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DTNBP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
184 supporting clones for gene DTNBP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_032122.4   .a 1 to 1418 1 to 1418 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1418/1418
(100 %)
0 diff
(100 %id)
DR007063 Spleen .a 14 to 633 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
BF975056 B-cells, primary B-cells from tonsils (cell line) .a 16 to 678 1 to 667   tiling clone,   667/1111
(60 %)
10 diff
(99.1 %id)
BU852002 mixed (pool of 40 RNAs) .a 16 to 278 1 to 263       263/297
(88 %)
6 diff
(98.0 %id)
BQ108775 brain, neuroblastoma, cell line .a 19 to 678 1 to 662       662/690
(95 %)
9 diff
(98.7 %id)
DN993429 brain, whole brain .a 36 to 659 1 to 624       624/624
(100 %)
4 diff
(99.4 %id)
CN256098 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 39 to 660 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BG761711 melanotic melanoma, high MDR (cell line), skin .a 39 to 615 1 to 578       578/754
(76 %)
6 diff
(99.3 %id)
BI093544 cervix .a 45 to 878 1 to 843       843/844
(99 %)
14 diff
(98.4 %id)
BP218418 caudate nucleus .a 61 to 648 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
AY265460 placenta .a 77 to 1410 1 to 1334 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1334/1334
(100 %)
0 diff
(100 %id)
DN990120 brain, whole brain .a 78 to 700 1 to 623       623/636
(97 %)
4 diff
(99.4 %id)
AF394226 brain .a 84 to 1410 1 to 1327 exact AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1327/1327
(100 %)
2 diff
(99.9 %id)
DC359176 lung .a 84 to 652 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BC011912 Muscle, rhabdomyosarcoma .a 86 to 1410 1 to 1325 exact available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1325/1325
(100 %)
1 diff
(100.0 %id)
BG033727 breast, mammary adenocarcinoma, cell line .a 87 to 678 1 to 593       593/1205
(49 %)
8 diff
(99.4 %id)
BM464138 melanotic melanoma, skin .a 87 to 1001 1 to 921       921/1101
(83 %)
15 diff
(98.7 %id)
CV571641 cornea, eye .a 89 to 673 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CD245171 White Matter .a 93 to 682 1 to 589   AAA   589/873
(67 %)
4 diff
(99.6 %id)
BE299122 muscle, rhabdomyosarcoma .a 105 to 633 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BE391484 endometrium, adenocarcinoma cell line, uterus .a 105 to 573 1 to 473       473/473
(100 %)
4 diff
(99.2 %id)
BQ709981 Spleen .a 123 to 1001 1 to 883       883/936
(94 %)
16 diff
(98.3 %id)
BQ899112 Spleen .a 133 to 965 1 to 835       835/836
(99 %)
7 diff
(99.2 %id)
BG394821 eye, retinoblastoma .a 137 to 678 1 to 546       546/948
(57 %)
10 diff
(99.0 %id)
CD251122 brain, Pituitary .a 140 to 1001 1 to 867       867/868
(99 %)
8 diff
(99.1 %id)
BM691708 eye, RPE and Choroid .a 147 to 536 1 to 390     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 390/390
(100 %)
11 diff
(97.2 %id)
CA488220   .a 154 to 908 1 to 758       758/896
(84 %)
12 diff
(98.7 %id)
BM772744 Ascites, stomach .a 163 to 779 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
CN256099 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 164 to 856 1 to 694       694/696
(99 %)
3 diff
(99.6 %id)
BQ049181 lymph, lymphoma, cell line .a 172 to 993 1 to 827       827/1039
(79 %)
10 diff
(99.1 %id)
CX784395 human embryonic stem cells .a 175 to 936 1 to 762       762/762
(100 %)
0 diff
(100 %id)
CD697444 normal nasopharynx .a 177 to 307 8 to 139       132/148
(89 %)
15 diff
(89.9 %id)
BQ319237 colon .a 247 to 580 54 to 387       334/387
(86 %)
8 diff
(98.0 %id)
BG681527 skin, squamous cell carcinoma .a 283 to 1112 1 to 844       842/844
(99 %)
28 diff
(96.7 %id)
BG681450 skin, squamous cell carcinoma .a 297 to 1108 14 to 818       812/818
(99 %)
19 diff
(97.7 %id)
TI_1948154233   .a 437 to 1244 936 to 127       810/1403
(57 %)
12 diff
(99.2 %id)
BQ334734 marrow .a 449 to 562 114 to 1       114/114
(100 %)
0 diff
(100 %id)
AF061734 brain .a 514 to 1408 1 to 895       895/895
(100 %)
0 diff
(100 %id)
BX343622 Placenta Cot 25-normalized .a 550 to 1381 833 to 1       833/833
(100 %)
6 diff
(99.3 %id)
BM794349 Ascites, stomach .a 560 to 1264 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
TI_1948154052   .a 676 to 1244 695 to 127       569/1459
(38 %)
0 diff
(100 %id)
TI_1948154138   .a 676 to 1244 699 to 131       569/1385
(41 %)
0 diff
(100 %id)
TI_149314283   .a 676 to 1410 821 to 87   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 735/955
(76 %)
0 diff
(100 %id)
TI_149312834   .a 678 to 1410 834 to 103   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 732/959
(76 %)
1 diff
(99.9 %id)
CB305880 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 684 to 1410 745 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 727/727
(100 %)
0 diff
(100 %id)
BG210157   .a 695 to 1403 712 to 8     Submitted on the opposite strand 705/938
(75 %)
18 diff
(98.1 %id)
BG198727   .a 698 to 1368 672 to 2     Submitted on the opposite strand 671/675
(99 %)
9 diff
(98.7 %id)
BG206525   .a 698 to 1209 1 to 514       514/769
(66 %)
24 diff
(96.9 %id)
BG211727   .a 698 to 1403 716 to 13     Submitted on the opposite strand 704/728
(96 %)
14 diff
(98.1 %id)
BG190062   .a 699 to 1403 715 to 10     Submitted on the opposite strand 706/718
(98 %)
19 diff
(97.4 %id)
AA043886 uterus .a 699 to 999 20 to 319       297/319
(93 %)
9 diff
(97.2 %id)
BG186872   .a 704 to 1403 709 to 9     Submitted on the opposite strand 701/711
(98 %)
10 diff
(98.6 %id)
BG189521   .a 705 to 1397 1 to 688       688/792
(86 %)
22 diff
(97.3 %id)
BG207053   .a 705 to 975 1 to 271       271/271
(100 %)
0 diff
(100 %id)
BG207545   .a 705 to 925 1 to 221       221/221
(100 %)
0 diff
(100 %id)
BG210172   .a 705 to 1397 1 to 690       690/695
(99 %)
12 diff
(98.3 %id)
BQ014623 Chondrosarcoma, Left Pubic Bone .a 706 to 1410 723 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 705/705
(100 %)
0 diff
(100 %id)
CD368888 Alveolar Macrophage, lung .a 706 to 1410 721 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 703/703
(100 %)
2 diff
(99.8 %id)
BQ008209 Chondrosarcoma, Left Pubic Bone .a 707 to 1410 719 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 701/701
(100 %)
3 diff
(99.6 %id)
BM978376 lung .a 708 to 1410 721 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
BG213833   .a 710 to 1403 704 to 9     Submitted on the opposite strand 696/864
(80 %)
19 diff
(97.9 %id)
BG196208   .a 711 to 1403 706 to 11     Submitted on the opposite strand 696/760
(91 %)
40 diff
(94.8 %id)
BF924534 nervous_tumor .a 731 to 998 272 to 5     Submitted on the opposite strand 268/272
(98 %)
1 diff
(99.7 %id)
CD366280 Alveolar Macrophage, lung .a 787 to 1410 642 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 624/624
(100 %)
0 diff
(100 %id)
AI928142 2 pooled tumors (clear cell type), Kidney .a 793 to 1371 620 to 42       579/620
(93 %)
0 diff
(100 %id)
TI_149285601   .a 800 to 1416 702 to 85   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 618/713
(86 %)
1 diff
(99.9 %id)
BM971507 lung .a 800 to 1416 636 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 618/632
(97 %)
1 diff
(99.9 %id)
FN152478 breast carcinoma .a 807 to 885 1 to 79       79/79
(100 %)
0 diff
(100 %id)
BG221571   .a 855 to 1390 553 to 20     Submitted on the opposite strand 534/761
(70 %)
15 diff
(98.1 %id)
BG215487   .a 859 to 1403 551 to 8     Submitted on the opposite strand 544/747
(72 %)
9 diff
(98.8 %id)
CA428487 cell lines, Chondrosarcoma .a 860 to 1405 569 to 24   AAA   546/551
(99 %)
2 diff
(99.7 %id)
FN100214 breast carcinoma .a 873 to 940 1 to 67       67/67
(100 %)
3 diff
(95.6 %id)
AW381568 head_neck .a 876 to 1299 425 to 5       421/425
(99 %)
4 diff
(99.1 %id)
AI718755 colon .a 885 to 1413 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AW024319 thymus, pooled .a 885 to 1416 533 to 1       533/533
(100 %)
3 diff
(99.5 %id)
BQ921250 leiomyosarcoma, uterus .a 890 to 1410 3 to 523   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 521/523
(99 %)
5 diff
(99.1 %id)
BM708245 eye, RPE and Choroid .a 902 to 1412 1 to 511   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 511/511
(100 %)
1 diff
(99.9 %id)
BG207052   .a 908 to 1409 509 to 8     Submitted on the opposite strand 502/512
(98 %)
0 diff
(100 %id)
BU947833 insulinoma, Pancreas .a 924 to 1421 498 to 1     Submitted on the opposite strand 498/498
(100 %)
5 diff
(99.0 %id)
BF439159 pooled .a 932 to 1413 487 to 6       482/487
(98 %)
0 diff
(100 %id)
AI760661 2 pooled tumors (clear cell type), Kidney .a 934 to 1409 491 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 476/476
(100 %)
3 diff
(99.4 %id)
AI056045   .a 942 to 1413 473 to 3       471/473
(99 %)
0 diff
(100 %id)
BU731332 eye, RPE and Choroid .a 947 to 1410 482 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 464/464
(100 %)
0 diff
(100 %id)
AI982597 pooled germ cell tumors .a 951 to 1410 460 to 1       460/460
(100 %)
0 diff
(100 %id)
DB558213 hypothalamus .a 969 to 1410 1 to 437     Submitted on the opposite strand 437/437
(100 %)
14 diff
(96.8 %id)
AI707892 aorta .a 974 to 1410 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
DB535192 hippocampus .a 978 to 1409 1 to 432     Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
AI394302 B-cell, chronic lymphotic leukemia .a 981 to 1410 443 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 430/430
(100 %)
4 diff
(99.1 %id)
DB556679 hypothalamus .a 983 to 1409 1 to 426     Submitted on the opposite strand 426/427
(99 %)
3 diff
(99.3 %id)
AI204457   .a 986 to 1413 429 to 2       428/429
(99 %)
0 diff
(100 %id)
AI281455 follicular lymphoma, lymph node .a 998 to 1410 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AA593131 colon .a 1004 to 1413 410 to 2       409/410
(99 %)
0 diff
(100 %id)
AA029125 uterus .a 1006 to 1319 322 to 4       319/322
(99 %)
0 diff
(100 %id)
BM662329 eye, RPE and Choroid .a 1018 to 1410 410 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
AA648433 germinal center B cell .a 1019 to 1410 416 to 26   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 391/391
(100 %)
1 diff
(99.8 %id)
W04790 lung .a 1023 to 1328 15 to 321       307/333
(92 %)
6 diff
(98.2 %id)
W04797 lung .a 1023 to 1391 1 to 370       370/372
(99 %)
2 diff
(99.5 %id)
AA614696 breast .a 1023 to 1410 402 to 15   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AA620896   .a 1030 to 1409 383 to 5       379/384
(98 %)
0 diff
(100 %id)
AI290838 carcinoid, lung .a 1041 to 1410 394 to 25   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 370/370
(100 %)
5 diff
(98.7 %id)
AW391560 stomach .a 1055 to 1399 346 to 4       343/346
(99 %)
0 diff
(100 %id)
AA688045 germinal center B cell .a 1059 to 1410 362 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 351/351
(100 %)
1 diff
(99.8 %id)
AI088504 uterus .a 1066 to 1410 370 to 26   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 345/345
(100 %)
14 diff
(96.0 %id)
AA810949 germinal center B cell .a 1083 to 1410 338 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 327/327
(100 %)
1 diff
(99.7 %id)
BG213834   .a 1085 to 1393 312 to 4     Submitted on the opposite strand 309/312
(99 %)
0 diff
(100 %id)
N23924 nose, olfactory epithelium .a 1095 to 1410 317 to 1       317/319
(99 %)
4 diff
(98.8 %id)
AW327545 blood, T cell leukemia .a 1096 to 1410 1 to 315   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 315/315
(100 %)
5 diff
(98.5 %id)
AI928728 anaplastic oligodendroglioma, brain .a 1099 to 1410 312 to 1       312/312
(100 %)
5 diff
(98.4 %id)
AW137237   .a 1106 to 1410 322 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 305/305
(100 %)
0 diff
(100 %id)
AI247804 liver and spleen .a 1114 to 1413 302 to 3       300/302
(99 %)
0 diff
(100 %id)
AI668987 Prostate .a 1116 to 1411 296 to 1       296/296
(100 %)
0 diff
(100 %id)
FN107939 breast carcinoma .a 1118 to 1182 1 to 64       64/64
(100 %)
1 diff
(98.5 %id)
AI097393 brain, glioblastoma (pooled) .a 1124 to 1418 317 to 23   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 295/295
(100 %)
6 diff
(98.0 %id)
AI264958 borderline ovarian carcinoma, ovary .a 1124 to 1410 298 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 287/287
(100 %)
0 diff
(100 %id)
AW327588 blood, T cell leukemia .a 1147 to 1410 284 to 21   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 264/264
(100 %)
1 diff
(99.7 %id)
AA890514 parathyroid gland, parathyroid tumor .a 1148 to 1410 276 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 263/263
(100 %)
0 diff
(100 %id)
BG182154   .a 1159 to 1403 293 to 48     Submitted on the opposite strand 246/293
(83 %)
0 diff
(100 %id)
DB529537 hippocampus .a 1168 to 1409 1 to 242     Submitted on the opposite strand 242/242
(100 %)
7 diff
(97.2 %id)
AW505075 lymph .a 1171 to 1410 1 to 240   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 240/240
(100 %)
6 diff
(97.5 %id)
BF345101 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1185 to 1410 1 to 222   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 222/222
(100 %)
5 diff
(97.8 %id)
BF345216 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1187 to 1413 1 to 225       225/240
(93 %)
10 diff
(95.9 %id)
AA768439 germinal center B cell .a 1227 to 1410 195 to 12   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 184/184
(100 %)
0 diff
(100 %id)
AI522225 Kidney .a 1236 to 1413 178 to 1       178/178
(100 %)
1 diff
(99.5 %id)
AI380312 B-cell, chronic lymphotic leukemia .a 1339 to 1410 85 to 14   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 72/72
(100 %)
1 diff
(98.7 %id)
BX394617 Neuroblastoma Cot 25-normalized .b 1 to 839 1 to 838   tiling clone, fully sequenced,   838/838
(100 %)
2 diff
(99.8 %id)
DB468022 hippocampus .b 62 to 520 1 to 459       459/459
(100 %)
2 diff
(99.6 %id)
CX873345 embryonic stem .b 79 to 806 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
DB119638 thymus .b 140 to 683 2 to 545   capped   544/545
(99 %)
0 diff
(100 %id)
BG751208 eye, normal pigmented retinal epithelium .b 153 to 817 1 to 668       668/979
(68 %)
6 diff
(99.4 %id)
BE731233 choriocarcinoma, placenta .b 161 to 817 1 to 658   tiling clone,   658/1179
(55 %)
2 diff
(99.9 %id)
BX394616 Neuroblastoma Cot 25-normalized .b 786 to 1516 731 to 1   tiling clone, fully sequenced,   731/731
(100 %)
3 diff
(99.6 %id)
BQ425964 leiomyosarcoma, uterus .c 1 to 603 1 to 605   tiling clone,   605/955
(63 %)
12 diff
(98.8 %id)
BQ440940 leiomyosarcoma, uterus .c 30 to 864 41 to 883       843/935
(90 %)
18 diff
(98.1 %id)
BQ056746 lymph, lymphoma, cell line .c 54 to 920 21 to 893       873/1038
(84 %)
16 diff
(98.5 %id)
BX343623 Placenta Cot 25-normalized .c 59 to 853 24 to 819   tiling clone,   796/819
(97 %)
6 diff
(99.3 %id)
AL559190.
matches multiple genes
T cells from T cell leukemia .c 59 to 652 24 to 618   fully sequenced, also hits gene INSL3 595/618
(96 %)
7 diff
(98.9 %id)
AL580857.
matches multiple genes
T cells from T cell leukemia .c 600 to 1255 712 to 57   tiling clone, fully sequenced, also hits gene INSL3 656/712
(92 %)
0 diff
(100 %id)
NM_183040.2   .d 1 to 1949 1 to 1949 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1949/1949
(100 %)
0 diff
(100 %id)
AK290718 lung .d 84 to 1281 1 to 1198 exact tiling clone,   1198/1198
(100 %)
0 diff
(100 %id)
AL136637 brain .d 88 to 1968 5 to 1887 D242V tiling clone, available from DKFZ,   1883/1892
(99 %)
6 diff
(99.7 %id)
AA679082 liver and spleen .d 1410 to 1927 518 to 1     Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
AI126268   .d 1554 to 1952 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AA055250 heart .d 1598 to 1941 1 to 348   fully sequenced,   348/348
(100 %)
5 diff
(98.6 %id)
AA055251 heart .d 1751 to 1949 205 to 1   fully sequenced,   205/205
(100 %)
0 diff
(100 %id)
NR_036448.1   .e 1 to 2088 1 to 2088 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2088/2088
(100 %)
0 diff
(100 %id)
AK310590 thymus .e 139 to 1680 1 to 1542 exact     1542/1542
(100 %)
1 diff
(100.0 %id)
DA917364 small intestine .e 601 to 1174 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BI861579 breast, mammary adenocarcinoma, cell line .f 1 to 664 1 to 670   tiling clone,   670/684
(97 %)
18 diff
(97.4 %id)
TI_57192507   .f 1 to 664 55 to 724       670/906
(73 %)
18 diff
(98.1 %id)
AK054593   .f 26 to 1404 1 to 1379 exact tiling clone, available from FLJ,   1379/1379
(100 %)
0 diff
(100 %id)
DA001223   .f 27 to 538 2 to 514   capped   513/523
(98 %)
2 diff
(99.7 %id)
DB294954   .f 866 to 1404 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BE793298 lung, small cell carcinoma .g 1 to 808 1 to 811 F164L E165R E166K A167L F168P ... tiling clone,   811/1038
(78 %)
13 diff
(98.8 %id)
CR623452 Neuroblastoma Cot 25-normalized .h 1 to 1518 1 to 1518 exact tiling clone,   1518/1518
(100 %)
0 diff
(100 %id)
CR998885 T-Lymphocytes .h 94 to 994 1 to 901       901/907
(99 %)
2 diff
(99.8 %id)
CR599171 T cells (Jurkat cell line) Cot10-normalized .i 1 to 1270 1 to 1270 exact tiling clone,   1270/1270
(100 %)
0 diff
(100 %id)
CR603457 Placenta Cot 25-normalized .i 1 to 1268 1 to 1268 exact     1268/1268
(100 %)
0 diff
(100 %id)
BM045624 carcinoma, cell line, Prostate .i 24 to 519 1 to 502       502/750
(66 %)
13 diff
(98.3 %id)
BP202776 amygdala .j 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
BP311224 brain .j 22 to 603 1 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
DT220970 brain .j 30 to 750 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
DB487333 hypothalamus .j 32 to 467 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
DB488848 hypothalamus .j 32 to 487 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
AV724633 hypothalamus .j 68 to 622 1 to 548       548/553
(99 %)
6 diff
(99.0 %id)
AA443730   .j 114 to 575 1 to 463   fully sequenced,   463/463
(100 %)
6 diff
(98.8 %id)
AA443420   .j 558 to 1012 455 to 1   tiling clone, fully sequenced,   455/455
(100 %)
0 diff
(100 %id)
BG699807 brain, hippocampus .k 1 to 677 1 to 686 K31R S34M K35Q P36T R37Q ... tiling clone,   686/721
(95 %)
28 diff
(96.2 %id)
BF307984 muscle, rhabdomyosarcoma .k 69 to 677 1 to 612 L9C L10* tiling clone,   612/680
(90 %)
17 diff
(97.5 %id)
CD109740 Human Placenta, placenta .k 106 to 677 28 to 601 E50D tiling clone,   574/788
(72 %)
14 diff
(98.3 %id)
AL711802 human skeletal muscle .m 1 to 499 1 to 500 E17* tiling clone,   500/500
(100 %)
3 diff
(99.4 %id)
AI299675 carcinoid, lung .n 1 to 419 1 to 419   tiling clone, Submitted on the opposite strand 419/419
(100 %)
2 diff
(99.6 %id)
AI299674 carcinoid, lung .n 9 to 425 1 to 417   tiling clone, Submitted on the opposite strand 417/417
(100 %)
6 diff
(98.6 %id)
CD172391 White Matter .o 1 to 824 1 to 834 exact tiling clone,   834/892
(93 %)
13 diff
(98.6 %id)
CA777742.
matches multiple genes
Pancreas, Purified pancreatic islet .o 185 to 848 14 to 677 Q13* tiling clone, fully sequenced, Submitted on the opposite strand, also hits gene NGFRAP1 664/677
(98 %)
6 diff
(99.2 %id)
CA777478.
matches multiple genes
Pancreas, Purified pancreatic islet .o 818 to 1401 584 to 1   tiling clone, fully sequenced, Submitted on the opposite strand, also hits gene NGFRAP1 584/584
(100 %)
0 diff
(100 %id)
BE175232 head_neck .p-u 1 to 283 7 to 287   tiling clone,   281/287
(97 %)
6 diff
(98.0 %id)
BG004446 placenta_normal .p-u 5 to 221 18 to 234   tiling clone,   217/248
(87 %)
6 diff
(97.6 %id)
CA450471 Human Lung Epithelial cells, lung .p-u 98 to 696 625 to 27 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 599/599
(100 %)
2 diff
(99.7 %id)
TI_153952998   .p-u 226 to 696 79 to 549 exact AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 471/549
(85 %)
6 diff
(99.0 %id)
BM661687 eye, Retina Foveal and Macular .p-u 235 to 696 480 to 19 exact AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 462/462
(100 %)
0 diff
(100 %id)
DB465987.
matches multiple genes
hippocampus .q-u 1 to 420 1 to 420 exact tiling clone, also hits gene flawglorbu 420/420
(100 %)
2 diff
(99.6 %id)
TI_57215000   .q-u 9 to 620 88 to 718 I3L C4A L5*     631/841
(75 %)
6 diff
(99.3 %id)
BI752857 brain .q-u 12 to 620 2 to 629 I3L C4A L5* tiling clone,   628/752
(83 %)
7 diff
(99.1 %id)
CR737548 lung .r 1 to 400 1 to 268 K14M F15D F16L E17M E18D ... tiling clone, Suspected internal deletion 268/268
(100 %)
1 diff
(99.7 %id)
AI337229 pooled germ cell tumors Gene DTNBP1, variant not shown         Suspected internal deletion, this clone was ignored    
AI685891 Prostate Gene DTNBP1, variant not shown         Suspected internal deletion, this clone was ignored    
BF064017 colon, colon tumor, RER+ Gene DTNBP1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG026373 Bone, osteosarcoma, cell line Gene DTNBP1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BQ071410 brain, neuroblastoma, cell line Gene DTNBP1, variant not shown         This clone was ignored    
BU507903 leiomyosarcoma, uterus Gene DTNBP1, variant not shown              
BU536623 mixed (pool of 40 RNAs) Gene DTNBP1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_1948154314   Gene DTNBP1, variant not shown         This clone was ignored    
DB001823 breast, tumor tissue Gene DTNBP1, variant not shown       capped This clone was ignored    
DB335202 breast, tumor tissue Gene DTNBP1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p-u, .q-u, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI